Molnuvir (Molnupiravir) 200 mg
Molnuvir 200 (Molnupiravir 200 mg) is an oral antiviral medication specifically designed to fight COVID-19.
Manufacturer: Sacred Leaves (India). This drug represents a game-changer in pandemic management, allowing for effective home treatment. One bottle contains 40 tablets, covering the complete 5-day treatment course.
Mechanism of Action ("Error Catastrophe"):
Molnupiravir works by introducing errors into the viral genetic code (RNA) of SARS-CoV-2. As the virus tries to replicate, it incorporates the drug into its RNA. This leads to an accumulation of mutations, known as "viral error catastrophe." The resulting viruses are defective and cannot survive or reproduce, effectively halting the infection.
β Key Benefit: Significantly reduces the risk of hospitalization and death if taken in the early stages of infection.
Indicated for the treatment of mild-to-moderate COVID-19 in adults:
- π¦ Target Group: Patients with a positive COVID-19 test who are at high risk for progression to severe disease (e.g., obesity, diabetes, heart disease, elderly).
- β° Timing: Treatment must be initiated as soon as possible, within 5 days of symptom onset.
Packaging: Bottle of 40 tablets (200 mg each).
β οΈ DOSAGE PROTOCOL:
- π Dose: 800 mg (take 4 tablets) every 12 hours.
- π Frequency: Twice daily (Morning and Evening). Total 8 tablets per day.
- π Duration: Continue for exactly 5 days. Complete the full course even if symptoms resolve.
- π€° Pregnancy: ABSOLUTELY CONTRAINDICATED. It poses a risk of fetal harm due to its mutagenic mechanism.
- πΆ Children: Not authorized for use in patients under 18 years (affects bone and cartilage growth).
- Breastfeeding is not recommended during treatment and for 4 days after the last dose.
Common adverse reactions include:
- π€’ Gastrointestinal: Diarrhea, nausea.
- π Nervous System: Dizziness, headache.
- Mild allergic reactions (rash).
What Customers Say
No reviews yet
Your review can be the first!